Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
imatinib (gleevec) (1 trial)
pembrolizumab (keytruda) (1 trial)
op-724 (2 trials)
Cholangitis (Phase 1)
Fibrosis (Phase 1)
Hemophilia A (Phase 1)
Liver Cirrhosis (Phase 1)
Liver Cirrhosis, Biliary (Phase 1)
Melanoma (Phase 2)
Trials (3 total)
Trial APIs (3 total)